Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Obstetrics and Gynecology|September 1, 1994
A new method of continuous vaginal cuff closure at abdominal hysterectomyM L Berman, E A GrosenJournal of Lower Genital Tract Disease|May 8, 2015
Pregnancy-related fibroadenoma of ectopic breast tissue in the vulvaE T Xanos, D A Kennedy, E A GrosenLymphokine and Cytokine Research|August 1, 1993
Release of soluble TNF/LT receptors from a human ovarian tumor cell line (PA-1) by stimulation with cytokines in vitroM Gatanaga, E A Grosen, R A Burger, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
Outpatient vaginal cuff brachytherapy for endometrial cancerD. G. Petereit, S. P. Tannehill, E. A. Grosen, et al.American Journal of Obstetrics and Gynecology|May 1, 1996
Hormone replacement therapy in breast cancer survivors: a cohort studyP J DiSaia, E A Grosen, T Kurosaki, et al.Cancer|November 15, 1995
Replacement therapy for breast cancer survivors. A pilot studyP J DiSaia, E A Grosen, F Odicino, et al.International Journal of Fertility and Women'S Medicine|September 28, 1999
An experience with estrogen replacement therapy in breast cancer survivorsW R Brewster, P J DiSaia, E A Grosen, et al.The Cancer Journal From Scientific American|December 22, 1999
Paclitaxel, carboplatin, and hexamethyl-melamine (taxchex) as first-line therapy for ovarian cancerE M Hartenbach, L S Harris, H H Bailey, et al.Gynecologic Oncology|July 1, 1993
Measurement of the soluble membrane receptors for tumor necrosis factor and lymphotoxin in the sera of patients with gynecologic malignancyE A Grosen, G A Granger, M Gatanaga, et al.Lymphokine and Cytokine Research|June 1, 1991
Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancerF Cappuccini, R S Yamamoto, P J DiSaia, et al.Pageof 2